Joseph Crookshank, MD
Interventional Pain Medicine · Lake Charles, LANPI 1710245964
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,234 of the $5,678 with a category attached, or 74.6%. 9 manufacturers reported payments, led by Boston Scientific at 42.2% of the total. Reporting peaked in 2019 at $1,936 and has fallen 77.2% since, to $441 in 2025.
Across 115 payments — averaging $49.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Vertiflex, Inc.$1K
- Relievant Medsystems, Inc.$1K
- Medtronic$298
- Nevro Corp.$295
- Foundation Fusion Solutions, LLC$217
- plus $113 from 3 others
What the payments were for
- Travel & lodging$1,44425%
- Food & beverage$4,23475%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 71 | $2,399 |
| Vertiflex, Inc. | 14 | $1,350 |
| Relievant Medsystems, Inc. | 9 | $1,005 |
| Medtronic(2 entities) | 7 | $298 |
| Nevro Corp. | 8 | $295 |
| Foundation Fusion Solutions, LLC | 1 | $217 |
| SPR Therapeutics, Inc | 3 | $71 |
| Spinal Simplicity, LLC | 1 | $26 |
| Sanara Medtech Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,655
- Superion ISS$1,114
- WaveWriter Alpha Prime 16$437
- GENERAL PAIN MANAGEMENT$242
- SUPERION$209
- INTELLIS$151
- Superion Indirect Decompression System$142
- Omnia$123
How this compares
$5,678 in reported general payments places this provider in the 55th percentile of 57 interventional pain medicine providers in Louisiana.
See all interventional pain medicine providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 243 | $2,772 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 89 | $700 |
| Tizanidine Hcl | 46 | $380 |
| Tramadol Hcl | 108 | $371 |
| Cephalexin | 32 | $300 |
| Methylprednisolone | 61 | $293 |
| Methocarbamol | 17 | $90 |
| Cyclobenzaprine Hcl | 13 | $81 |
| Meloxicam | 19 | $57 |
| Diazepam | 52 | $49 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Lake Charles
- Maged GuirguisNew Orleans$565K
- Suneil JollyKenner$107K
- John CefaluShreveport$71K
- Steve LeeSlidell$57K
- William WhyteShreveport$39K
- Paul HubbellMetairie$33K
- Ken EhrhardtHammond$22K
- Thomas BerryLacombe$21K
- Randall BrewerShreveport$19K
- Corey Ann ConnCovinton$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.